Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antoni Torres

Showing results (351-360 of 794) with videos related to

Pageof 80
Sort By:
Scientific Reports|June 20, 2018
Impact of bronchiectasis on outcomes of hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease: A propensity matched analysisErnesto Crisafulli, Mónica Guerrero, Antonella Ielpo, et al.
Critical Care Medicine|June 27, 2012
Association between systemic corticosteroids and outcomes of intensive care unit-acquired pneumoniaOtavio Tavares Ranzani, Miquel Ferrer, Mariano Esperatti, et al.
Respirology (Carlton, Vic.)|January 18, 2017
Seasonality of pathogens causing community-acquired pneumoniaCatia Cilloniz, Santiago Ewig, Albert Gabarrus, et al.
Archives of Internal Medicine|April 27, 2005
Microbiologic determinants of exacerbation in chronic obstructive pulmonary diseaseAntoni Rosell, Eduard Monsó, Néstor Soler, et al.
Critical Care (London, England)|February 8, 2005
Ethics roundtable debate: A patient dies from an ICU-acquired infection related to methicillin-resistant Staphylococcus aureus--how do you defend your case and your team?Jean-Louis Vincent, Christian Brun-Buisson, Michael Niederman, et al.
Chest|May 15, 2013
Impact of age and comorbidity on cause and outcome in community-acquired pneumoniaCatia Cillóniz, Eva Polverino, Santiago Ewig, et al.
Ebiomedicine|September 30, 2017
Lymphopenic Community Acquired Pneumonia (L-CAP), an Immunological Phenotype Associated with Higher Risk of MortalityJesus F Bermejo-Martin, Catia Cilloniz, Raul Mendez, et al.
Medicina Clinica|October 3, 2002
[Diagnostic methods and treatment of community-acquired pneumonia in Spain: NACE study]María Rosa Celis, Antoni Torres, Rafael Zalacaín, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 22, 2016
Phenotypic shift in Pseudomonas aeruginosa populations from cystic fibrosis lungs after 2-week antipseudomonal treatmentLaia Fernández-Barat, Oana Ciofu, Kasper N Kragh, et al.
American Journal of Respiratory and Critical Care Medicine|February 25, 2026
From severity-guided to CRP-guided corticosteroid treatmentJim M Smit, Jesse H Krijthe, Melanie Lloyd, et al.
Pageof 80

Showing results (351-360 of 794) with videos related to

Sort By:
Pageof 80
Scientific Reports|June 20, 2018
Impact of bronchiectasis on outcomes of hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease: A propensity matched analysisErnesto Crisafulli, Mónica Guerrero, Antonella Ielpo, et al.
Critical Care Medicine|June 27, 2012
Association between systemic corticosteroids and outcomes of intensive care unit-acquired pneumoniaOtavio Tavares Ranzani, Miquel Ferrer, Mariano Esperatti, et al.
Respirology (Carlton, Vic.)|January 18, 2017
Seasonality of pathogens causing community-acquired pneumoniaCatia Cilloniz, Santiago Ewig, Albert Gabarrus, et al.
Archives of Internal Medicine|April 27, 2005
Microbiologic determinants of exacerbation in chronic obstructive pulmonary diseaseAntoni Rosell, Eduard Monsó, Néstor Soler, et al.
Critical Care (London, England)|February 8, 2005
Ethics roundtable debate: A patient dies from an ICU-acquired infection related to methicillin-resistant Staphylococcus aureus--how do you defend your case and your team?Jean-Louis Vincent, Christian Brun-Buisson, Michael Niederman, et al.
Chest|May 15, 2013
Impact of age and comorbidity on cause and outcome in community-acquired pneumoniaCatia Cillóniz, Eva Polverino, Santiago Ewig, et al.
Ebiomedicine|September 30, 2017
Lymphopenic Community Acquired Pneumonia (L-CAP), an Immunological Phenotype Associated with Higher Risk of MortalityJesus F Bermejo-Martin, Catia Cilloniz, Raul Mendez, et al.
Medicina Clinica|October 3, 2002
[Diagnostic methods and treatment of community-acquired pneumonia in Spain: NACE study]María Rosa Celis, Antoni Torres, Rafael Zalacaín, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 22, 2016
Phenotypic shift in Pseudomonas aeruginosa populations from cystic fibrosis lungs after 2-week antipseudomonal treatmentLaia Fernández-Barat, Oana Ciofu, Kasper N Kragh, et al.
American Journal of Respiratory and Critical Care Medicine|February 25, 2026
From severity-guided to CRP-guided corticosteroid treatmentJim M Smit, Jesse H Krijthe, Melanie Lloyd, et al.
Pageof 80